Dr. Lama Matni Abdelnour, MD

Dr. Abdelnour practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Abdelnour's NPI, 1477817542, was assigned on July 3, 2012. Dr. Abdelnour graduated from Faculty of Medicine of Albaath University in 2008. Dr. Abdelnour holds California license A135151.

Dr. Abdelnour's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Abdelnour's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Abdelnour is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Abdelnour to 1 more hospital, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelnour practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Abdelnour's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Abdelnour is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Abdelnour's licenses on file in 2 states: California and Nevada.

Dmand AI lists chronic kidney disease and kidney cysts among the conditions Dr. Abdelnour treats.

CMS data shows 873 Medicare services from Dr. Abdelnour across 7 procedure codes in 2024, for 215 Medicare patients. Medicare paid $73,377 for them.

CMS counts 215 Medicare patients who saw Dr. Abdelnour in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 4.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelnour's median patient age at 60, with 48% women.

In 2024, Dr. Abdelnour wrote 2,089 Medicare Part D claims for 237 patients. 89% of them were for generic drugs. CMS names the drug for 1,814 of them, across 46 drugs with 11 or more claims each, at $375,269 in total drug cost. In 2023, CMS named 1,832 claims across 47 drugs.

Dr. Abdelnour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdelnour as offering telehealth.

Dmand AI links 3 papers to Dr. Abdelnour, published from 2019 to 2023. Dr. Abdelnour's most frequent co-authors are Ramy Magdy Hanna, MD, Rebecca S. Ahdoot, MD and Antoney Joseph Ferrey, MD.

CMS Open Payments shows 65 general payments to Dr. Abdelnour from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $17,509.

Dr. Abdelnour graduated from Faculty of Medicine of Albaath University in 2008.

Dr. Abdelnour is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.